title: Value-based medicine: a new paradigm to evaluate treatments for vitreoretinal diseases and other medical interventions.
authors.affiliation: Ophthalmic Consultants of Boston, MA 02114, USA.
authors.forename: Brandon G
authors.initials: BG
authors.lastname: Busbee
authors.forename: Gary C
authors.initials: GC
authors.lastname: Brown
authors.forename: Melissa M
authors.initials: MM
authors.lastname: Brown
mesh_terms: D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D003695:Delivery of Health Care / Q000191:economics; D005128:Eye Diseases / Q000191:economics* / Q000628:therapy; D017048:Health Care Costs; D006801:Humans; D012164:Retinal Diseases / Q000191:economics* / Q000628:therapy; D014822:Vitreous Body